Round One Expressions of Interest Is Now Closed
This opportunity is offered by the Commonwealth under the Targeted Translation Research Accelerator (TTRA) Program which forms part of the Medical Research Future Fund (MRFF).
The TTRA Research Projects funding can provide between $200,000 - $750,000 to help eligible organisations develop innovative preventative, diagnostic, therapeutic and disease management products/solutions for identified priorities associated with diabetes and cardiovascular disease.
TTRA Research Projects Expressions of Interests must address one of the following Priority Areas:
- Priority 1: Mental health conditions in people living with at least two of the following: Type 1 diabetes, Type 2 diabetes and/or cardiovascular disease; or
- Priority 2: Chronic kidney disease in people living with at least two of the following: Type 1 diabetes, Type 2 diabetes and/or cardiovascular disease; or
- Priority 3: Cardiac and vascular complications arising in people living with diabetes (Type 1 or Type 2) and cardiovascular disease; OR Cardiovascular disease in people living with Type 1 diabetes and insulin resistance (double diabetes).
The project term for funded TTRA Research Projects is a maximum of 24 months. Applicants will be required to provide an in-kind contribution to the value of 50% of the TTRA funding request to be eligible. Additional in-kind or cash contributions above this threshold will be viewed favourably.
Please review the detailed Guidelines for further information about eligibility and the application process. All submissions must be made through SmartyGrants with a link provided below. The sample EOI application form provides an overview of what is required in your EOI.
For queries, please contact the TTRA team via email on firstname.lastname@example.org.
Listen to the MTPConnect Podcast to learn more about this opportunity.